Epitomee Medical

Israel
Caesarea, Haifa, Israel, 3079563

Company profile

Epitomee Medical company profile

Epitomee develops paradigm-shifting ingestible devices that deploy targeted therapies along the GI tract. The company develops and commercializes ingestible therapeutic devices with the goal of addressing some of today's most common chronic diseases in a self-managed, safer, kinder to the system, and more manageable manner. Their technology is based on self-expanding hydro-gel scaffolds folded into a standard pharmaceutical capsule, produced from biocompatible excipients, food additives, and food contact materials.

Business identity

Contact email
[email protected]
Phone number
+972.722.505.995
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2005-01-01, Year

Headquarters

Postal code
3079563
Country code
IL
Continent
Asia

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
1
Total equity funding
$8M
Last funding
Series A / $8M / 2019-04-09
Last equity funding
Series A / $8M
Investors
3
Lead investors
1
Founders
1
Articles
12
Exited on
2021-12-14

Founders and investors

Founders

Shimon Eckhouse

Lead investors

XT Venture Capital

Investors

GCB ServicesShimon EckhouseXT Venture Capital